Compugroup Medical (ETR:COP) has been given a €56.00 ($66.67) target price by stock analysts at Warburg Research in a research report issued to clients and investors on Thursday. The firm presently has a “buy” rating on the stock. Warburg Research’s price objective suggests a potential downside of 0.62% from the company’s previous close.

Several other analysts also recently issued reports on the stock. Baader Bank set a €52.00 ($61.90) price target on shares of Compugroup Medical and gave the company a “neutral” rating in a report on Thursday, November 9th. Deutsche Bank set a €65.00 ($77.38) price target on shares of Compugroup Medical and gave the company a “buy” rating in a report on Tuesday, November 14th. Commerzbank set a €62.00 ($73.81) price target on shares of Compugroup Medical and gave the company a “buy” rating in a report on Monday, November 13th. Finally, Berenberg Bank set a €53.00 ($63.10) price target on shares of Compugroup Medical and gave the company a “neutral” rating in a report on Friday, November 10th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Compugroup Medical currently has an average rating of “Buy” and a consensus price target of €58.17 ($69.25).

Shares of Compugroup Medical (ETR COP) opened at €56.35 ($67.08) on Thursday. Compugroup Medical has a fifty-two week low of €36.12 ($43.00) and a fifty-two week high of €57.70 ($68.69).

WARNING: “Warburg Research Analysts Give Compugroup Medical (COP) a €56.00 Price Target” was first posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.dailypolitical.com/2017/12/14/warburg-research-analysts-give-compugroup-medical-cop-a-56-00-price-target.html.

About Compugroup Medical

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.